These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10558441)

  • 1. Cysteamine: new preparation. Chronic treatment of cystinosis.
    Prescrire Int; 1999 Jun; 8(41):67-70. PubMed ID: 10558441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of cystinosis in children with twice-daily cysteamine.
    Dohil R; Gangoiti JA; Cabrera BL; Fidler M; Schneider JA; Barshop BA
    J Pediatr; 2010 May; 156(5):823-7. PubMed ID: 20138296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
    Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
    Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cysteamine in the treatment of cystinosis in children. In vitro and in vivo studies].
    Louis JJ; Guibaud P; Dumoulin R; Parchoux B; Zabot MT; Bureau J; Baltassat P; Frederich A; Larbre F
    Pediatrie; 1984 Dec; 39(8):619-33. PubMed ID: 6535971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteamine therapy for children with nephropathic cystinosis.
    Gahl WA; Reed GF; Thoene JG; Schulman JD; Rizzo WB; Jonas AJ; Denman DW; Schlesselman JJ; Corden BJ; Schneider JA
    N Engl J Med; 1987 Apr; 316(16):971-7. PubMed ID: 3550461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of cystinosis using cysteamine].
    Broyer M; Tete MJ
    Ann Pediatr (Paris); 1990 Feb; 37(2):91-3. PubMed ID: 2321906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved renal function in children with cystinosis treated with cysteamine.
    Markello TC; Bernardini IM; Gahl WA
    N Engl J Med; 1993 Apr; 328(16):1157-62. PubMed ID: 8455682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephropathic cystinosis: effect of long-term cysteamine therapy.
    Proesmans W; Baten E; Hoogmartens J; Bruyneel P
    Clin Nephrol; 1987 Jun; 27(6):309-12. PubMed ID: 3608256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cystinosis with cysteamine. A pilot study determining dose and form of application.
    Bergonzi E; Herren A; Lavanchy P; Bühlmann C; Wyss SR; Lüthy C; Oetliker O
    Helv Paediatr Acta; 1981 Nov; 36(5):437-43. PubMed ID: 7031022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity.
    Bendel-Stenzel MR; Steinke J; Dohil R; Kim Y
    Pediatr Nephrol; 2008 Feb; 23(2):311-5. PubMed ID: 17668247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of infantile nephropathic cystinosis with cysteamine.
    da Silva VA; Zurbrügg RP; Lavanchy P; Blumberg A; Suter H; Wyss SR; Lüthy CM; Oetliker OH
    N Engl J Med; 1985 Dec; 313(23):1460-3. PubMed ID: 4058549
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of cysteamine therapy in nephropathic cystinosis.
    Yudkoff M; Foreman JW; Segal S
    N Engl J Med; 1981 Jan; 304(3):141-5. PubMed ID: 7442733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephropathic cystinosis in children: An overlooked disease.
    Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis.
    Kimonis VE; Troendle J; Rose SR; Yang ML; Markello TC; Gahl WA
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3257-61. PubMed ID: 7593434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
    Ahlenstiel-Grunow T; Kanzelmeyer NK; Froede K; Kreuzer M; Drube J; Lerch C; Pape L
    Pediatr Nephrol; 2017 Jan; 32(1):91-97. PubMed ID: 27350621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy.
    Tsilou ET; Rubin BI; Reed G; Caruso RC; Iwata F; Balog J; Gahl WA; Kaiser-Kupfer MI
    Ophthalmology; 2006 Jun; 113(6):1002-9. PubMed ID: 16603246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate.
    Besouw M; Tangerman A; Cornelissen E; Rioux P; Levtchenko E
    Mol Genet Metab; 2012 Sep; 107(1-2):234-6. PubMed ID: 22832073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intra-leukocyte cystine in cystinosis treated with cysteamine].
    Ged C; Jean G; Tete MJ; Broyer M; Kamoun P
    Ann Biol Clin (Paris); 1991; 49(9):482-6. PubMed ID: 1789502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone producing prolactinoma in juvenile cystinosis: a simple coincidence?
    Besouw MT; Levtchenko EN; Willemsen MA; Noordam K
    Pediatr Nephrol; 2008 Feb; 23(2):307-10. PubMed ID: 17638022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of infantile nephropathic cystinosis with cysteamine.
    N Engl J Med; 1986 May; 314(20):1319-21. PubMed ID: 3702933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.